Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Nature Communications|November 8, 2024
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemiaDominik Beck, Honghui Cao, Feng Tian, et al.
Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.
Nature Communications|August 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.
Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Cancer Cell|December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged LeukemiaAndrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Cancer Cell|September 14, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Nature|January 24, 2022
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAMTobias V Lanz, R Camille Brewer, Peggy P Ho, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Nature Communications|November 8, 2024
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemiaDominik Beck, Honghui Cao, Feng Tian, et al.
Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.
Nature Communications|August 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.
Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Cancer Cell|December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged LeukemiaAndrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Cancer Cell|September 14, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Nature|January 24, 2022
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAMTobias V Lanz, R Camille Brewer, Peggy P Ho, et al.
Pageof 22